“Abnormal Expression of WSB1 in Lung Adenocarcinoma: A Potential Prognostic and Immunotherapeutic Sensitivity Biomarker”. Advances in World Medical Research, vol. 1, no. 2, Dec. 2025, pp. 48-63, https://doi.org/10.71204/1bcv8650.